Sarah Alrasheed: New Evidence on Transitioning From Parenteral Prostacyclin to Selexipag
Sarah Alrasheed, Associate Consultant in Pulmonary Medicine at King Faisal Specialist Hospital and Research Center, shared on LinkedIn:
“I am pleased to share that our latest research has been published in Pulmonary Circulation. In this study, we address a critical and sensitive clinical question: the transition from parenteral prostacyclin therapy to Selexipag.
Until now, many of us in clinical practice have had limited evidence to guide whether transitioning to oral prostacyclin pathway therapy is safe and feasible, and most importantly: what the safety implications of this decision are for our patients. Our findings aim to provide practical, real world guidance to support clinicians facing this complex decision.
I hope this work proves valuable for your practice and for the care of patients with pulmonary hypertension.
You can access the article here.”
Article: Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study
Authors: Brandon Budhram, Sarah K. Alrasheed, Moaaz Rashad, George Chandy, Anna Dvorkin-Gheva, George A. Fox, Julia Foxall, Andrea Gardner, Doug Helmersen, Naushad Hirani, Kristina Kemp, Mithum Kularatne, David Langleben, Lyda Lesenko, Steeve Provencher, Emma Spence, John R. Swiston, Mitesh Thakrar, Daniel Wadden, Jason Weatherald, Nathan Hambly
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 23, 2026, 20:46Grace Choung: A Novel CFHR5 Copy Number Variant in Postpartum Atypical HUS
-
Jul 23, 2026, 20:10Mohammad Alzoubi: One Month of Dual Antithrombotic Therapy After PCI Was Non-Inferior to 12 Months
-
Jul 23, 2026, 20:08Ahmed Bennis: Calcitriol Replenishment May Mitigate Ischemic Risk in MASLD
-
Jul 23, 2026, 20:06Mitsuaki Sawano: Can Cardiovascular Risk Prediction Models Developed in One Population be Reliably Applied to Another?
-
Jul 23, 2026, 20:05Abdul Muqtadir Abbasi: Hemostasis Isn’t About Memorizing Factor Numbers – It’s About Recognizing Patterns
-
Jul 23, 2026, 19:40Maureen Macharia: How Apixaban Transformed Modern Anticoagulation
-
Jul 23, 2026, 19:30Jordan Agay: Why We Need to Track the Neurological Costs of Anemia
-
Jul 23, 2026, 19:25William Archibald: Key Takeaways on VTE Cost-Effectiveness and Cancer Associated Thrombosis from ISTH 2026
-
Jul 23, 2026, 19:17Diego López Santos: Donation after Donation, I Just Reached 100